Hydration Pharmaceuticals Company Ltd has released a press release.
Q3 FY23 Quarterly Activities Report (App 4C)
Filed with ASX ·
6ix hasn’t read this filing yet.
Hydration Pharmaceuticals Company Limited on 6ix
In the deck
Story so far
Earlier from Hydration Pharmaceuticals
- July Trading Update
- FY23 Half Year Results Announcement
- Appendix 4D and FY23 Half Year Financial Report
- Extension of Entitlement Offer Closing Date
- RLG: RLG Contracted to Market and Sell Hydralyte in China
Later from Hydration Pharmaceuticals
- Q4 FY23 Quarterly Activities Report (App 4C)
- FY23 Appendix 4E
- Variation to Facility Agreement with PURE Asset Management
- Waiver of ASX Listing Rule 10.1 Granted
- Q1 FY24 Quarterly Activities Report (App 4C)
Follow Hydration Pharmaceuticals into a list and get an email when it puts out news.
Follow Hydration Pharmaceuticals